Log in to save to my catalogue

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c3c0ec24bd94a4f8b4bb6f04557df41

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

About this item

Full title

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

Author / Creator

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2023-05, Vol.15 (5), p.1527

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Inflammation resolution is an active process via specialized pro-resolving mediators (SPMs) to fight invading microbes and repair tissue injury. RvD1 and RvD2 are SPMs produced from DHA during inflammation responses and show a benefit in treating inflammation disorders, but it is not completely understood how they act on vasculature and immune cell...

Alternative Titles

Full title

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3c3c0ec24bd94a4f8b4bb6f04557df41

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c3c0ec24bd94a4f8b4bb6f04557df41

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics15051527

How to access this item